Home › Prostate Cancer › Georgia
Prostate Cancer clinical trials in Georgia
41 studies for Prostate Cancer are looking for participants at sites in Georgia.
Cities in Georgia
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Emory University, Atlanta
RecruitingPhase 4
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT07569926Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Augusta University Research Institute, Augusta
Recruiting
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06496256A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Emory University Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06095089A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Emory Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tennessee Oncology, PLLC - Dalton, Dalton
- Tennessee Oncology, PLLC - Ringgold, Ringgold
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University Cancer and Blood Center LLC, Athens
- Emory University, Atlanta
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Atlanta, Newnan
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University Cancer and Blood Center LLC, Athens
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07114601A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Newnan
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- and 3 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Northside Hospital, Atlanta
- Northside Hospital - Duluth, Duluth
- Northside Hospital - Gwinnett, Lawrenceville
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- CTCA at Southeastern Regional Medical Center, Newnan
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT07200830Prostate Active Surveillance Study
- Emory University, Atlanta
RecruitingObservational study
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Northeast Georgia Medical Center Braselton, Braselton
- Atlanta VA Medical Center, Decatur
- Northeast Georgia Medical Center-Gainesville, Gainesville
- and 3 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Emory University - Winship Cancer Institute, Atlanta
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Emory University, Atlanta
RecruitingPhase 1
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Emory University Hospital, Atlanta
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT06785636A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Winship Cancer Institute, Emory University, Atlanta
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Emory University, Atlanta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07288359An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
- Emory University Hospital, Atlanta
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06865768Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- and 4 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- University Cancer and Blood Center LLC, Athens
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Emory University Hospital, Atlanta
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 14, 2026 · NCT05413850Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
- Georgia College & State University, Milledgeville
Recruiting
Ages 18 and older · Men · Updated Apr 1, 2026 · NCT06651359T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Emory University, Atlanta
RecruitingPhase 2
Ages 18 and older · Men · Updated Mar 4, 2026 · NCT05586360REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Feb 24, 2026 · NCT06650579Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Atlanta
RecruitingPhase 1/2
Ages 18 to 130 · Men · Updated Feb 23, 2026 · NCT06267729Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
- Emory University Hospital/Winship Cancer Institute, Atlanta
Recruiting
Ages 18 and older · Men · Updated Feb 17, 2026 · NCT04725903Improving Health Literacy in African-American Prostate Cancer Patients
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- and 1 more
Recruiting
Ages 25 to 100 · Men · Updated Jan 29, 2026 · NCT03322891cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- North Georgia Health System, Gainesville
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
- Emory University, Atlanta
RecruitingPhase 1/2
Ages 18 to 90 · Men · Updated Dec 19, 2025 · NCT06262139Addressing Health Literacy With a Tailored Survivorship Care Plan
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Recruiting
Ages 18 and older · Men · Updated Dec 9, 2025 · NCT06674863A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 114, Atlanta
- Research Site 139, Atlanta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.